|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.98 USD | +0.73% |
|
-3.43% | -38.60% |
| 05-13 | Ajax Therapeutics, Inc. announced that it has received $95 million in funding from a group of investors | CI |
| 05-07 | Ansys Partners With Schrodinger to Accelerate Materials Development | MT |
Schrödinger, Inc. provided revenue guidance for the year 2022. For the year, the company expects revenue expected to range from $161 million to $181 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -38.60% | 1.6B | |
| +14.39% | 3,197B | |
| +14.08% | 89.6B | |
| +8.04% | 80.08B | |
| -12.15% | 55.52B | |
| +22.36% | 46.79B | |
| +31.67% | 46.34B | |
| -29.01% | 43.95B | |
| +77.73% | 41.34B | |
| -3.95% | 26.5B |
SCHRÖDINGER, INC. 
